Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
Rhoda Sperling(MDS Associates (United States)), John L. Sullivan, John A. Todd(University of Oxford), David E. Shapiro(Intercept Pharmaceuticals (United States)), Steven A. Herman(Roche (Switzerland)), Robert W. Coombs(University of Namur), Christine Rouzioux(Université Paris Cité), Eleanor Jiménez(University of Miami), Russell B. Van Dyke(Tulane University), George McSherry(Rutgers New Jersey Medical School), Mary Jo O’Sullivan(University at Buffalo, State University of New York), Patricia M. Flynn(St. Jude Children's Research Hospital)
Cited by 51
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.7k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|Nature Genetics|2007|1.5k